Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), bought 160 shares at $13.10 ($2K) on 2021-11-18, disclosed to the SEC on 2021-11-19.
Open-market purchase of $2k URGN by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |